Global Implantable Drug-Eluting Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
The Implantable Drug-Eluting Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Implantable Drug-Eluting Devices market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Diabetes accounting for % of the Implantable Drug-Eluting Devices global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Implantable Drug Infusion Pumps segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Implantable Drug-Eluting Devices include Pfizer, Medtronic, Merck, Bayer AG, and Johnson & Johnson, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Implantable Drug-Eluting Devices market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Implantable Drug Infusion Pumps
Intraocular Drug-Eluting Devices
Contraceptive Drug-Eluting Devices
Drug-Eluting Stents
Others
Market segment by Application can be divided into
Diabetes
Contraception
HIV/AIDS Prevention
Chronic Pain Management
Cardiovascular
Ophthalmology
Oncology
Others
The key market players for global Implantable Drug-Eluting Devices market are listed below:
Pfizer
Medtronic
Merck
Bayer AG
Johnson & Johnson
Abbott
Surmodics
Boston Scientific Corporation
Titan Pharmaceuticals, Inc.
BIOTRONIK
Allergan
Bausch & Lomb
REVA Medical
MicroPort Medical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Implantable Drug-Eluting Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Implantable Drug-Eluting Devices, with price, sales, revenue and global market share of Implantable Drug-Eluting Devices from 2019 to 2022.
Chapter 3, the Implantable Drug-Eluting Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Implantable Drug-Eluting Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Implantable Drug-Eluting Devices market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Implantable Drug-Eluting Devices.
Chapter 13, 14, and 15, to describe Implantable Drug-Eluting Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Implantable Drug-Eluting Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Implantable Drug-Eluting Devices Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Implantable Drug Infusion Pumps
1.2.3 Intraocular Drug-Eluting Devices
1.2.4 Contraceptive Drug-Eluting Devices
1.2.5 Drug-Eluting Stents
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Implantable Drug-Eluting Devices Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Diabetes
1.3.3 Contraception
1.3.4 HIV/AIDS Prevention
1.3.5 Chronic Pain Management
1.3.6 Cardiovascular
1.3.7 Ophthalmology
1.3.8 Oncology
1.3.9 Others
1.4 Global Implantable Drug-Eluting Devices Market Size & Forecast
1.4.1 Global Implantable Drug-Eluting Devices Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Implantable Drug-Eluting Devices Sales in Volume (2017-2028)
1.4.3 Global Implantable Drug-Eluting Devices Price (2017-2028)
1.5 Global Implantable Drug-Eluting Devices Production Capacity Analysis
1.5.1 Global Implantable Drug-Eluting Devices Total Production Capacity (2017-2028)
1.5.2 Global Implantable Drug-Eluting Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Implantable Drug-Eluting Devices Market Drivers
1.6.2 Implantable Drug-Eluting Devices Market Restraints
1.6.3 Implantable Drug-Eluting Devices Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Implantable Drug-Eluting Devices Product and Services
2.1.4 Pfizer Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business
2.2.3 Medtronic Implantable Drug-Eluting Devices Product and Services
2.2.4 Medtronic Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Implantable Drug-Eluting Devices Product and Services
2.3.4 Merck Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Bayer AG
2.4.1 Bayer AG Details
2.4.2 Bayer AG Major Business
2.4.3 Bayer AG Implantable Drug-Eluting Devices Product and Services
2.4.4 Bayer AG Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Implantable Drug-Eluting Devices Product and Services
2.5.4 Johnson & Johnson Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business
2.6.3 Abbott Implantable Drug-Eluting Devices Product and Services
2.6.4 Abbott Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Surmodics
2.7.1 Surmodics Details
2.7.2 Surmodics Major Business
2.7.3 Surmodics Implantable Drug-Eluting Devices Product and Services
2.7.4 Surmodics Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Boston Scientific Corporation
2.8.1 Boston Scientific Corporation Details
2.8.2 Boston Scientific Corporation Major Business
2.8.3 Boston Scientific Corporation Implantable Drug-Eluting Devices Product and Services
2.8.4 Boston Scientific Corporation Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Titan Pharmaceuticals, Inc.
2.9.1 Titan Pharmaceuticals, Inc. Details
2.9.2 Titan Pharmaceuticals, Inc. Major Business
2.9.3 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Product and Services
2.9.4 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 BIOTRONIK
2.10.1 BIOTRONIK Details
2.10.2 BIOTRONIK Major Business
2.10.3 BIOTRONIK Implantable Drug-Eluting Devices Product and Services
2.10.4 BIOTRONIK Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Allergan
2.11.1 Allergan Details
2.11.2 Allergan Major Business
2.11.3 Allergan Implantable Drug-Eluting Devices Product and Services
2.11.4 Allergan Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Bausch & Lomb
2.12.1 Bausch & Lomb Details
2.12.2 Bausch & Lomb Major Business
2.12.3 Bausch & Lomb Implantable Drug-Eluting Devices Product and Services
2.12.4 Bausch & Lomb Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 REVA Medical
2.13.1 REVA Medical Details
2.13.2 REVA Medical Major Business
2.13.3 REVA Medical Implantable Drug-Eluting Devices Product and Services
2.13.4 REVA Medical Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 MicroPort Medical
2.14.1 MicroPort Medical Details
2.14.2 MicroPort Medical Major Business
2.14.3 MicroPort Medical Implantable Drug-Eluting Devices Product and Services
2.14.4 MicroPort Medical Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Implantable Drug-Eluting Devices Breakdown Data by Manufacturer
3.1 Global Implantable Drug-Eluting Devices Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Implantable Drug-Eluting Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Implantable Drug-Eluting Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Implantable Drug-Eluting Devices Manufacturer Market Share in 2021
3.4.2 Top 6 Implantable Drug-Eluting Devices Manufacturer Market Share in 2021
3.5 Global Implantable Drug-Eluting Devices Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Implantable Drug-Eluting Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Implantable Drug-Eluting Devices Market Size by Region
4.1.1 Global Implantable Drug-Eluting Devices Sales in Volume by Region (2017-2028)
4.1.2 Global Implantable Drug-Eluting Devices Revenue by Region (2017-2028)
4.2 North America Implantable Drug-Eluting Devices Revenue (2017-2028)
4.3 Europe Implantable Drug-Eluting Devices Revenue (2017-2028)
4.4 Asia-Pacific Implantable Drug-Eluting Devices Revenue (2017-2028)
4.5 South America Implantable Drug-Eluting Devices Revenue (2017-2028)
4.6 Middle East and Africa Implantable Drug-Eluting Devices Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Implantable Drug-Eluting Devices Sales in Volume by Type (2017-2028)
5.2 Global Implantable Drug-Eluting Devices Revenue by Type (2017-2028)
5.3 Global Implantable Drug-Eluting Devices Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Implantable Drug-Eluting Devices Sales in Volume by Application (2017-2028)
6.2 Global Implantable Drug-Eluting Devices Revenue by Application (2017-2028)
6.3 Global Implantable Drug-Eluting Devices Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Implantable Drug-Eluting Devices Sales by Type (2017-2028)
7.2 North America Implantable Drug-Eluting Devices Sales by Application (2017-2028)
7.3 North America Implantable Drug-Eluting Devices Market Size by Country
7.3.1 North America Implantable Drug-Eluting Devices Sales in Volume by Country (2017-2028)
7.3.2 North America Implantable Drug-Eluting Devices Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Implantable Drug-Eluting Devices Sales by Type (2017-2028)
8.2 Europe Implantable Drug-Eluting Devices Sales by Application (2017-2028)
8.3 Europe Implantable Drug-Eluting Devices Market Size by Country
8.3.1 Europe Implantable Drug-Eluting Devices Sales in Volume by Country (2017-2028)
8.3.2 Europe Implantable Drug-Eluting Devices Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Implantable Drug-Eluting Devices Sales by Type (2017-2028)
9.2 Asia-Pacific Implantable Drug-Eluting Devices Sales by Application (2017-2028)
9.3 Asia-Pacific Implantable Drug-Eluting Devices Market Size by Region
9.3.1 Asia-Pacific Implantable Drug-Eluting Devices Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Implantable Drug-Eluting Devices Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Implantable Drug-Eluting Devices Sales by Type (2017-2028)
10.2 South America Implantable Drug-Eluting Devices Sales by Application (2017-2028)
10.3 South America Implantable Drug-Eluting Devices Market Size by Country
10.3.1 South America Implantable Drug-Eluting Devices Sales in Volume by Country (2017-2028)
10.3.2 South America Implantable Drug-Eluting Devices Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Implantable Drug-Eluting Devices Sales by Type (2017-2028)
11.2 Middle East & Africa Implantable Drug-Eluting Devices Sales by Application (2017-2028)
11.3 Middle East & Africa Implantable Drug-Eluting Devices Market Size by Country
11.3.1 Middle East & Africa Implantable Drug-Eluting Devices Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Implantable Drug-Eluting Devices Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Implantable Drug-Eluting Devices and Key Manufacturers
12.2 Manufacturing Costs Percentage of Implantable Drug-Eluting Devices
12.3 Implantable Drug-Eluting Devices Production Process
12.4 Implantable Drug-Eluting Devices Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Implantable Drug-Eluting Devices Typical Distributors
13.3 Implantable Drug-Eluting Devices Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Implantable Drug-Eluting Devices Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Implantable Drug-Eluting Devices Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Implantable Drug-Eluting Devices Product and Services
Table 6. Pfizer Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Medtronic Basic Information, Manufacturing Base and Competitors
Table 8. Medtronic Major Business
Table 9. Medtronic Implantable Drug-Eluting Devices Product and Services
Table 10. Medtronic Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Implantable Drug-Eluting Devices Product and Services
Table 14. Merck Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 16. Bayer AG Major Business
Table 17. Bayer AG Implantable Drug-Eluting Devices Product and Services
Table 18. Bayer AG Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 20. Johnson & Johnson Major Business
Table 21. Johnson & Johnson Implantable Drug-Eluting Devices Product and Services
Table 22. Johnson & Johnson Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Abbott Basic Information, Manufacturing Base and Competitors
Table 24. Abbott Major Business
Table 25. Abbott Implantable Drug-Eluting Devices Product and Services
Table 26. Abbott Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Surmodics Basic Information, Manufacturing Base and Competitors
Table 28. Surmodics Major Business
Table 29. Surmodics Implantable Drug-Eluting Devices Product and Services
Table 30. Surmodics Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 32. Boston Scientific Corporation Major Business
Table 33. Boston Scientific Corporation Implantable Drug-Eluting Devices Product and Services
Table 34. Boston Scientific Corporation Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Titan Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 36. Titan Pharmaceuticals, Inc. Major Business
Table 37. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Product and Services
Table 38. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. BIOTRONIK Basic Information, Manufacturing Base and Competitors
Table 40. BIOTRONIK Major Business
Table 41. BIOTRONIK Implantable Drug-Eluting Devices Product and Services
Table 42. BIOTRONIK Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Allergan Basic Information, Manufacturing Base and Competitors
Table 44. Allergan Major Business
Table 45. Allergan Implantable Drug-Eluting Devices Product and Services
Table 46. Allergan Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Bausch & Lomb Basic Information, Manufacturing Base and Competitors
Table 48. Bausch & Lomb Major Business
Table 49. Bausch & Lomb Implantable Drug-Eluting Devices Product and Services
Table 50. Bausch & Lomb Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. REVA Medical Basic Information, Manufacturing Base and Competitors
Table 52. REVA Medical Major Business
Table 53. REVA Medical Implantable Drug-Eluting Devices Product and Services
Table 54. REVA Medical Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. MicroPort Medical Basic Information, Manufacturing Base and Competitors
Table 56. MicroPort Medical Major Business
Table 57. MicroPort Medical Implantable Drug-Eluting Devices Product and Services
Table 58. MicroPort Medical Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Global Implantable Drug-Eluting Devices Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 60. Global Implantable Drug-Eluting Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 61. Market Position of Manufacturers in Implantable Drug-Eluting Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 62. Global Implantable Drug-Eluting Devices Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Implantable Drug-Eluting Devices Production Site of Key Manufacturer
Table 64. Implantable Drug-Eluting Devices New Entrant and Capacity Expansion Plans
Table 65. Implantable Drug-Eluting Devices Mergers & Acquisitions in the Past Five Years
Table 66. Global Implantable Drug-Eluting Devices Sales by Region (2017-2022) & (K Units)
Table 67. Global Implantable Drug-Eluting Devices Sales by Region (2023-2028) & (K Units)
Table 68. Global Implantable Drug-Eluting Devices Revenue by Region (2017-2022) & (USD Million)
Table 69. Global Implantable Drug-Eluting Devices Revenue by Region (2023-2028) & (USD Million)
Table 70. Global Implantable Drug-Eluting Devices Sales by Type (2017-2022) & (K Units)
Table 71. Global Implantable Drug-Eluting Devices Sales by Type (2023-2028) & (K Units)
Table 72. Global Implantable Drug-Eluting Devices Revenue by Type (2017-2022) & (USD Million)
Table 73. Global Implantable Drug-Eluting Devices Revenue by Type (2023-2028) & (USD Million)
Table 74. Global Implantable Drug-Eluting Devices Price by Type (2017-2022) & (USD/Unit)
Table 75. Global Implantable Drug-Eluting Devices Price by Type (2023-2028) & (USD/Unit)
Table 76. Global Implantable Drug-Eluting Devices Sales by Application (2017-2022) & (K Units)
Table 77. Global Implantable Drug-Eluting Devices Sales by Application (2023-2028) & (K Units)
Table 78. Global Implantable Drug-Eluting Devices Revenue by Application (2017-2022) & (USD Million)
Table 79. Global Implantable Drug-Eluting Devices Revenue by Application (2023-2028) & (USD Million)
Table 80. Global Implantable Drug-Eluting Devices Price by Application (2017-2022) & (USD/Unit)
Table 81. Global Implantable Drug-Eluting Devices Price by Application (2023-2028) & (USD/Unit)
Table 82. North America Implantable Drug-Eluting Devices Sales by Country (2017-2022) & (K Units)
Table 83. North America Implantable Drug-Eluting Devices Sales by Country (2023-2028) & (K Units)
Table 84. North America Implantable Drug-Eluting Devices Revenue by Country (2017-2022) & (USD Million)
Table 85. North America Implantable Drug-Eluting Devices Revenue by Country (2023-2028) & (USD Million)
Table 86. North America Implantable Drug-Eluting Devices Sales by Type (2017-2022) & (K Units)
Table 87. North America Implantable Drug-Eluting Devices Sales by Type (2023-2028) & (K Units)
Table 88. North America Implantable Drug-Eluting Devices Sales by Application (2017-2022) & (K Units)
Table 89. North America Implantable Drug-Eluting Devices Sales by Application (2023-2028) & (K Units)
Table 90. Europe Implantable Drug-Eluting Devices Sales by Country (2017-2022) & (K Units)
Table 91. Europe Implantable Drug-Eluting Devices Sales by Country (2023-2028) & (K Units)
Table 92. Europe Implantable Drug-Eluting Devices Revenue by Country (2017-2022) & (USD Million)
Table 93. Europe Implantable Drug-Eluting Devices Revenue by Country (2023-2028) & (USD Million)
Table 94. Europe Implantable Drug-Eluting Devices Sales by Type (2017-2022) & (K Units)
Table 95. Europe Implantable Drug-Eluting Devices Sales by Type (2023-2028) & (K Units)
Table 96. Europe Implantable Drug-Eluting Devices Sales by Application (2017-2022) & (K Units)
Table 97. Europe Implantable Drug-Eluting Devices Sales by Application (2023-2028) & (K Units)
Table 98. Asia-Pacific Implantable Drug-Eluting Devices Sales by Region (2017-2022) & (K Units)
Table 99. Asia-Pacific Implantable Drug-Eluting Devices Sales by Region (2023-2028) & (K Units)
Table 100. Asia-Pacific Implantable Drug-Eluting Devices Revenue by Region (2017-2022) & (USD Million)
Table 101. Asia-Pacific Implantable Drug-Eluting Devices Revenue by Region (2023-2028) & (USD Million)
Table 102. Asia-Pacific Implantable Drug-Eluting Devices Sales by Type (2017-2022) & (K Units)
Table 103. Asia-Pacific Implantable Drug-Eluting Devices Sales by Type (2023-2028) & (K Units)
Table 104. Asia-Pacific Implantable Drug-Eluting Devices Sales by Application (2017-2022) & (K Units)
Table 105. Asia-Pacific Implantable Drug-Eluting Devices Sales by Application (2023-2028) & (K Units)
Table 106. South America Implantable Drug-Eluting Devices Sales by Country (2017-2022) & (K Units)
Table 107. South America Implantable Drug-Eluting Devices Sales by Country (2023-2028) & (K Units)
Table 108. South America Implantable Drug-Eluting Devices Revenue by Country (2017-2022) & (USD Million)
Table 109. South America Implantable Drug-Eluting Devices Revenue by Country (2023-2028) & (USD Million)
Table 110. South America Implantable Drug-Eluting Devices Sales by Type (2017-2022) & (K Units)
Table 111. South America Implantable Drug-Eluting Devices Sales by Type (2023-2028) & (K Units)
Table 112. South America Implantable Drug-Eluting Devices Sales by Application (2017-2022) & (K Units)
Table 113. South America Implantable Drug-Eluting Devices Sales by Application (2023-2028) & (K Units)
Table 114. Middle East & Africa Implantable Drug-Eluting Devices Sales by Region (2017-2022) & (K Units)
Table 115. Middle East & Africa Implantable Drug-Eluting Devices Sales by Region (2023-2028) & (K Units)
Table 116. Middle East & Africa Implantable Drug-Eluting Devices Revenue by Region (2017-2022) & (USD Million)
Table 117. Middle East & Africa Implantable Drug-Eluting Devices Revenue by Region (2023-2028) & (USD Million)
Table 118. Middle East & Africa Implantable Drug-Eluting Devices Sales by Type (2017-2022) & (K Units)
Table 119. Middle East & Africa Implantable Drug-Eluting Devices Sales by Type (2023-2028) & (K Units)
Table 120. Middle East & Africa Implantable Drug-Eluting Devices Sales by Application (2017-2022) & (K Units)
Table 121. Middle East & Africa Implantable Drug-Eluting Devices Sales by Application (2023-2028) & (K Units)
Table 122. Implantable Drug-Eluting Devices Raw Material
Table 123. Key Manufacturers of Implantable Drug-Eluting Devices Raw Materials
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Implantable Drug-Eluting Devices Typical Distributors
Table 127. Implantable Drug-Eluting Devices Typical Customers
List of Figures
Figure 1. Implantable Drug-Eluting Devices Picture
Figure 2. Global Implantable Drug-Eluting Devices Revenue Market Share by Type in 2021
Figure 3. Implantable Drug Infusion Pumps
Figure 4. Intraocular Drug-Eluting Devices
Figure 5. Contraceptive Drug-Eluting Devices
Figure 6. Drug-Eluting Stents
Figure 7. Others
Figure 8. Global Implantable Drug-Eluting Devices Revenue Market Share by Application in 2021
Figure 9. Diabetes
Figure 10. Contraception
Figure 11. HIV/AIDS Prevention
Figure 12. Chronic Pain Management
Figure 13. Cardiovascular
Figure 14. Ophthalmology
Figure 15. Oncology
Figure 16. Others
Figure 17. Global Implantable Drug-Eluting Devices Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 18. Global Implantable Drug-Eluting Devices Revenue and Forecast (2017-2028) & (USD Million)
Figure 19. Global Implantable Drug-Eluting Devices Sales (2017-2028) & (K Units)
Figure 20. Global Implantable Drug-Eluting Devices Price (2017-2028) & (USD/Unit)
Figure 21. Global Implantable Drug-Eluting Devices Production Capacity (2017-2028) & (K Units)
Figure 22. Global Implantable Drug-Eluting Devices Production Capacity by Geographic Region: 2022 VS 2028
Figure 23. Implantable Drug-Eluting Devices Market Drivers
Figure 24. Implantable Drug-Eluting Devices Market Restraints
Figure 25. Implantable Drug-Eluting Devices Market Trends
Figure 26. Global Implantable Drug-Eluting Devices Sales Market Share by Manufacturer in 2021
Figure 27. Global Implantable Drug-Eluting Devices Revenue Market Share by Manufacturer in 2021
Figure 28. Implantable Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 29. Top 3 Implantable Drug-Eluting Devices Manufacturer (Revenue) Market Share in 2021
Figure 30. Top 6 Implantable Drug-Eluting Devices Manufacturer (Revenue) Market Share in 2021
Figure 31. Global Implantable Drug-Eluting Devices Sales Market Share by Region (2017-2028)
Figure 32. Global Implantable Drug-Eluting Devices Revenue Market Share by Region (2017-2028)
Figure 33. North America Implantable Drug-Eluting Devices Revenue (2017-2028) & (USD Million)
Figure 34. Europe Implantable Drug-Eluting Devices Revenue (2017-2028) & (USD Million)
Figure 35. Asia-Pacific Implantable Drug-Eluting Devices Revenue (2017-2028) & (USD Million)
Figure 36. South America Implantable Drug-Eluting Devices Revenue (2017-2028) & (USD Million)
Figure 37. Middle East & Africa Implantable Drug-Eluting Devices Revenue (2017-2028) & (USD Million)
Figure 38. Global Implantable Drug-Eluting Devices Sales Market Share by Type (2017-2028)
Figure 39. Global Implantable Drug-Eluting Devices Revenue Market Share by Type (2017-2028)
Figure 40. Global Implantable Drug-Eluting Devices Price by Type (2017-2028) & (USD/Unit)
Figure 41. Global Implantable Drug-Eluting Devices Sales Market Share by Application (2017-2028)
Figure 42. Global Implantable Drug-Eluting Devices Revenue Market Share by Application (2017-2028)
Figure 43. Global Implantable Drug-Eluting Devices Price by Application (2017-2028) & (USD/Unit)
Figure 44. North America Implantable Drug-Eluting Devices Sales Market Share by Type (2017-2028)
Figure 45. North America Implantable Drug-Eluting Devices Sales Market Share by Application (2017-2028)
Figure 46. North America Implantable Drug-Eluting Devices Sales Market Share by Country (2017-2028)
Figure 47. North America Implantable Drug-Eluting Devices Revenue Market Share by Country (2017-2028)
Figure 48. United States Implantable Drug-Eluting Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Canada Implantable Drug-Eluting Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Mexico Implantable Drug-Eluting Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Europe Implantable Drug-Eluting Devices Sales Market Share by Type (2017-2028)
Figure 52. Europe Implantable Drug-Eluting Devices Sales Market Share by Application (2017-2028)
Figure 53. Europe Implantable Drug-Eluting Devices Sales Market Share by Country (2017-2028)
Figure 54. Europe Implantable Drug-Eluting Devices Revenue Market Share by Country (2017-2028)
Figure 55. Germany Implantable Drug-Eluting Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. France Implantable Drug-Eluting Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. United Kingdom Implantable Drug-Eluting Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Russia Implantable Drug-Eluting Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Italy Implantable Drug-Eluting Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Asia-Pacific Implantable Drug-Eluting Devices Sales Market Share by Region (2017-2028)
Figure 61. Asia-Pacific Implantable Drug-Eluting Devices Sales Market Share by Application (2017-2028)
Figure 62. Asia-Pacific Implantable Drug-Eluting Devices Sales Market Share by Region (2017-2028)
Figure 63. Asia-Pacific Implantable Drug-Eluting Devices Revenue Market Share by Region (2017-2028)
Figure 64. China Implantable Drug-Eluting Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Japan Implantable Drug-Eluting Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Korea Implantable Drug-Eluting Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. India Implantable Drug-Eluting Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Southeast Asia Implantable Drug-Eluting Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Australia Implantable Drug-Eluting Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South America Implantable Drug-Eluting Devices Sales Market Share by Type (2017-2028)
Figure 71. South America Implantable Drug-Eluting Devices Sales Market Share by Application (2017-2028)
Figure 72. South America Implantable Drug-Eluting Devices Sales Market Share by Country (2017-2028)
Figure 73. South America Implantable Drug-Eluting Devices Revenue Market Share by Country (2017-2028)
Figure 74. Brazil Implantable Drug-Eluting Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Argentina Implantable Drug-Eluting Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Middle East & Africa Implantable Drug-Eluting Devices Sales Market Share by Type (2017-2028)
Figure 77. Middle East & Africa Implantable Drug-Eluting Devices Sales Market Share by Application (2017-2028)
Figure 78. Middle East & Africa Implantable Drug-Eluting Devices Sales Market Share by Region (2017-2028)
Figure 79. Middle East & Africa Implantable Drug-Eluting Devices Revenue Market Share by Region (2017-2028)
Figure 80. Turkey Implantable Drug-Eluting Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Egypt Implantable Drug-Eluting Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Saudi Arabia Implantable Drug-Eluting Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. South Africa Implantable Drug-Eluting Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. Manufacturing Cost Structure Analysis of Implantable Drug-Eluting Devices in 2021
Figure 85. Manufacturing Process Analysis of Implantable Drug-Eluting Devices
Figure 86. Implantable Drug-Eluting Devices Industrial Chain
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
Figure 88. Methodology
Figure 89. Research Process and Data Source
